Fri, Aug 29, 2014, 4:07 AM EDT - U.S. Markets open in 5 hrs 23 mins


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • mandoesit mandoesit May 6, 2013 6:11 PM Flag

    ACAD Buyout Talk. LINK

    The StreetInsider May 6, 2013
    Article :Jefferies Maintains Bullish Stance on Acadia Pharmaceuticals (ACAD) after Management Meetings
    Jefferies reiterated its Buy rating and $18 price target on Acadia Pharmaceuticals (NASDAQ: ACAD) Monday following positive management meetings.
    Analyst Thomas Wei is positive on developments for Acadia's pimavanserin.
    "We had an opportunity to meet with ACAD management recently and are incrementally encouraged by commentary on manufacturing timelines for pimavanserin, the rate limiting step to filing, as well ascommentary on outside interest in pimavanserin from pharma companies," the analyst said. "We continue to see up to six months of upside potential to the company's guidance for a late 2014 filing.

4.12-0.10(-2.37%)Aug 28 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.